clofazimine has been researched along with atovaquone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| El-Saber Batiha, G; Igarashi, I; Magdy Beshbishy, A; Nadwa, E; Rashwan, E; Stephen Adeyemi, O; Yokoyama, N | 1 |
| Ahedor, B; Batmagnai, E; Igarashi, I; Liu, M; Nugraha, AB; Otgonsuren, D; Sivakumar, T; Tuvshintulga, B; Xuan, X; Yokoyama, N | 1 |
| Baghdadi, HB; El-Sayed, SAE; Eltaysh, R; Igarashi, I; Rizk, MA | 1 |
1 review(s) available for clofazimine and atovaquone
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
4 other study(ies) available for clofazimine and atovaquone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Atovaquone; Babesia; Cell Survival; Clofazimine; Diminazene; Dogs; Eflornithine; Foreskin; Humans; Hydroxyurea; Male; Mice; NIH 3T3 Cells; Theileria | 2020 |
Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Clofazimine; Drug Therapy, Combination; Humans; Immunocompromised Host; Mice | 2022 |
Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis.
Topics: Animals; Atovaquone; Babesia microti; Babesiosis; Clofazimine; Cysteine Proteases; Drug Repositioning; Imidocarb; Malaria; Mice; Theileria | 2022 |